Program Schedule

81
National Estimates of Pediatric Infectious Disease Hospitalizations from 1997-2009:† An Analysis of the Kidsí Inpatient Database

Session: Oral Abstract Session: Defining and Reducing the Impact of Pediatric Infections
Thursday, October 9, 2014: 9:30 AM
Room: The Pennsylvania Convention Center: 111-AB

Background: †Infectious diseases are a major source of morbidity and mortality in children. In this study, we sought to identify and generate national estimates of the primary infectious disease diagnoses associated with pediatric hospitalizations.

Methods: † We analyzed a nationwide, stratified probability sample of hospital discharges among children <18 years that was weighted using a complex survey design to 36.3 million discharges over a five year period, including:† 1997, 2000, 2003, 2006, and 2009. Primary infectious disease discharge diagnoses were identified using the Clinical Classification Software and Major Diagnostic Categories, which were developed for use with the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database.

Results: Annually, 687,000 of 7.3 million (9.4%) pediatric discharges were associated with a primary infectious disease diagnosis. The proportion of pediatric hospitalizations with a primary infectious disease discharge diagnosis decreased from 11.2 to 8.8% from 1997 to 2009 (P<0.001). After newborn deliveries, infectious diseases were the leading cause of pediatric hospitalization. Eight conditions accounted for more than 80% of pediatric infectious disease discharge diagnoses (Table). Respiratory tract infections accounted for 63% of all pediatric infectious disease hospitalizations.

Conclusion: Infectious diseases are a leading cause of pediatric hospitalizations, led by pneumonia and bronchiolitis. Infectious disease diagnoses were the primary diagnosis for approximately 10% of all pediatric hospitalizations and a substantial proportion of health expenditures.

Chris Stockmann, MSc1, Adam L. Hersh, MD, PhD2, Kwabena Ampofo, MD3, Carrie L. Byington, MD4, Catherine Sherwin, PhD1, Michael Spigarelli, MD, PhD1 and Andrew Pavia, MD, FIDSA, FSHEA5, (1)University of Utah Health Sciences Center, Salt Lake City, UT, (2)University of Utah School of Medicine, Salt Lake City, UT, (3)Pediatric Infectious Disease, University of Utah SOM, Salt Lake City, UT, (4)Pediatrics, University of Utah, Salt Lake City, UT, (5)Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT

Disclosures:

C. Stockmann, None

A. L. Hersh, None

K. Ampofo, None

C. L. Byington, None

C. Sherwin, None

M. Spigarelli, None

A. Pavia, None

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek